Cardiovascular disease is the major cause of mortality and disability, with hypertension
being the most prevalent risk factor. Excessive activation of the renin-angiotensin system …

Countries around the world continue to address the largescale health and wellbeing impacts
and the broader societal burden associated with the coronavirus disease 2019 (COVID …

Exposure to the spike protein or receptor-binding domain (S-RBD) of SARS-CoV-2
significantly influences endothelial cells and induces pulmonary vascular endotheliopathy …

Abstract Coronavirus disease 2019 (COVID-19) is caused by the novel severe acute
respiratory coronavirus-2 (SARS-CoV-2). Several explanations for the development of …

As the world progressively recovers from the acute stages of the coronavirus disease 2019
(COVID-19) pandemic, we may be facing new challenges regarding the long-term …

Hemodynamic disturbance, a rise in neutrophil-to-lymphocyte ratio (NLR) and release of
inflammatory cytokines into blood, is a bad prognostic indicator in severe COVID-19 and …

Pulmonary arterial hypertension (PAH) is a pulmonary vascular disease characterized by
the progressive elevation of pulmonary arterial pressures. It is becoming increasingly …

Statistics Canada estimated that approximately 1.4 million Canadians suffer from long
COVID. Although cardiovascular changes during acute SARS-CoV-2 infection are well …

Pulmonary hypertension (PH) is a severe and chronic disease characterized by increased
pulmonary vascular resistance and remodeling, often precipitating right-sided heart …

Patient: Female, 49-year-old Final Diagnosis: Adult-onset Still's• pulmonary hypertension
Symptoms: Shortness of breath Clinical Procedure:—Specialty: Cardiology• General and …